Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Family Planning: The Responsibility to Prevent Both Pregnancy and Reproductive Tract Infections

  • Chapter
Reproductive Tract Infections

Part of the book series: Reproductive Biology ((RBIO))

Abstract

Using contraception has two main benefits: prevention of unplanned pregnancy and protection against reproductive tract infections (RTIs).1–4 But technology development, policy emphasis, and service delivery have focused almost solely on preventing pregnancy, with little attention paid to reducing RTIs. Abstinence from sexual intercourse provides nearly absolute protection against both outcomes. For those choosing to be sexually active, contraception reduces, but does not eliminate, the risk of either pregnancy or RTIs. Unfortunately, the contraceptives with the best record for pregnancy prevention provide minimal RTI protection. Some contraceptives may even raise the risk of certain infections. Thus, decisions about contraception by individuals, communities, and policymakers should involve balancing the relative need to prevent both RTIs and unplanned pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grimes DA, Cates W, Jr. Family planning and sexually transmitted diseases. In: Holmes KK, Mârdh P-A, Sparling PF et al., eds. Sexually transmitted diseases, second edition, New York: McGraw-Hill, 1990: 1087–94.

    Google Scholar 

  2. Harlap S, Kost K, Forrest JD. Preventing pregnancy, protecting health: a new look at birth control choices in the United States, New York: The Alan Guttmacher Institute, 1991.

    Google Scholar 

  3. DaVanzo J, Parnell AM, Foege WH. Health consequences of contraceptive use and reproductive patterns. JAMA 1991; 265: 2692–6.

    Article  PubMed  CAS  Google Scholar 

  4. Cates W Jr. Sexually transmitted diseases and family planning. Strange or natural bedfellows? J Reprod Med 1984; 29: 317–22.

    Google Scholar 

  5. Luker K. Contraceptive risk taking and abortion. Stud Fam Plann 1977; 8: 190–6.

    Article  PubMed  CAS  Google Scholar 

  6. Horowitz DR, Oechsli W. Contraceptive risk-taking in a population with limited access to abortion. J Biosoc Sci 1980; 12: 373–82.

    Article  PubMed  CAS  Google Scholar 

  7. Hatcher RA, Stewart FA, Trussell TJ, et al., eds. Contraceptive Technology, 1990–1992, 15th edition, New York: Irvington Press, 1990.

    Google Scholar 

  8. Hearst N, Hulley SB. Preventing the heterosexual spread of AIDS: are we giving our patients the best advice? JAMA 1988; 259: 2428–32.

    Article  PubMed  CAS  Google Scholar 

  9. May RM, Anderson RM. Transmission dynamics of HIV infection. Nature 1987; 326: 137–42.

    Article  PubMed  CAS  Google Scholar 

  10. Caldwell JC, Caldwell P. The cultural context of high fertility in Sub-Saharan Africa. Popul Develop Rev 1987; 13: 409–37.

    Article  Google Scholar 

  11. Caldwell JC, Caldwell P, Quiggin P. The social context of AIDS in Sub-Saharan Africa. Popul Develop Rev 1989; 15: 185–234.

    Article  Google Scholar 

  12. Fineberg HB. Education to prevent AIDS: prospects and obstacles. Science 1988; 239: 592–6.

    Article  PubMed  CAS  Google Scholar 

  13. Eisenberg B. The number of partners and the probability of HIV infection. Statistics Med 1989; 8: 83–92.

    Article  CAS  Google Scholar 

  14. Reiss IL, Leik RK. Evaluating strategies to avoid AIDS: number of partners versus use of condoms. J Sex Res 1989; 26: 411–33.

    Article  Google Scholar 

  15. Cates W Jr, Rolfs RT Jr, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease and infertility: an epidemiologic update. Epidemiol Rev 1990; 12: 199–220.

    PubMed  Google Scholar 

  16. Widdus R, Meheus A, Short R. The management of risk in sexually transmitted diseases. Daedalus 1990; 119: 177–91.

    Google Scholar 

  17. Aral SO, Guinan ME. Women and sexually transmitted diseases. In: Holmes KK, Mârdh P-A, Sparling PF, Wiesner PJ, eds. Sexually transmitted diseases, first edition, New York: McGraw-Hill, 1984: 85–9.

    Google Scholar 

  18. Sobel JD. Vaginal infections in adult women. Med Clin N Amer 1990; 74: 1573–1602.

    PubMed  CAS  Google Scholar 

  19. Rolfs RT, Galaid EI, Zaidi AA. Pelvic inflammatory disease: trends in hospitalizations and office visits, 1979–1988. Submitted for publication, 1991.

    Google Scholar 

  20. Drotman DP. Epidemiology and treatment of epididymitis. Rev Infect Dis 1982; Suppl 4: S788–93.

    Google Scholar 

  21. Krieger JN. Prostatitis syndromes: pathophysiology, differential diagnosis, and treatment. Sex Transm Dis 1984; 11: 100–12.

    Article  PubMed  CAS  Google Scholar 

  22. Larson A. Social context of human immunodeficiency virus transmission in Africa: historical and cultural bases of East and Central African sexual relations. Rev Infect Dis 1989; 11: 716–24.

    Article  PubMed  CAS  Google Scholar 

  23. Cates W Jr. The epidemiology and control of sexually transmitted diseases in adolescents. In: Schydlower M, Shafer M-A, eds. AIDS and the other sexually transmitted diseases. Adolesc Med State Art Rev 1990; 3: 409–27.

    Google Scholar 

  24. Henshaw SK, Van Vort J. Abortion services in the United States, 1987 and 1988. Fam Plann Perspect 1990; 22: 102–9.

    Article  PubMed  CAS  Google Scholar 

  25. Aral SO, Holmes KK. Epidemiology of sexual behavior and sexually transmitted diseases. In: Holmes KK, Mârdh P-A, Sparling PF et al., eds. Sexually transmitted diseases, second edition, New York: McGraw-Hill, 1990: 19–36.

    Google Scholar 

  26. Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med 1989; 321: 7–12.

    Article  PubMed  CAS  Google Scholar 

  27. Mosher WD. Fecundity and infertility in the United States. Am J Public Health 1988; 78: 181–2.

    Article  PubMed  CAS  Google Scholar 

  28. Platt R, Rice PA, McCormack WM. Risk of acquiring gonorrhea and prevalence of abnormal adnexal findings among women recently exposed to gonorrhea. JAMA 1983; 250: 3205–9.

    Article  PubMed  CAS  Google Scholar 

  29. Hooper RR, Reynolds GH, Jones OG et al. Cohort study of venereal disease. I. The risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978; 108: 136–44.

    PubMed  CAS  Google Scholar 

  30. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin N Amer 1990; 74: 1339–52.

    PubMed  CAS  Google Scholar 

  31. Trussell J, Kost K. Contraceptive failure in the United States: a critical review of the literature. Stud Fam Plann 1987; 18: 237–83.

    Article  PubMed  CAS  Google Scholar 

  32. CDC. Number of sex partners and potential risk of sexual exposure to human immunodeficiency virus. MMWR 1988; 37: 565–8.

    Google Scholar 

  33. Mastroianni L Jr, Donaldson PJ, Kane TT. Development of contraceptives-obstacles and opportunities. N Engl J Med 1990; 322: 482–4.

    Article  PubMed  Google Scholar 

  34. Peterson HB, Galaid EI, Zenilman JM. Pelvic inflammatory disease: review of treatment options. Rev Infect Dis 1990; 12 (Suppl 6): S656–64.

    Article  PubMed  Google Scholar 

  35. Department of Health and Human Services, Office of Population Affairs. Guidelines for clinical practice for facilities funded under Title X, Washington, DC, 1989.

    Google Scholar 

  36. Parra W, Drotman DP, Siegel K, Esteves K, Baker T. Patient counseling and behavior modification. In: Holmes KK, Mârdh P-A, Sparling PF et al., eds. Sexually transmitted diseases, second edition, New York: McGraw-Hill, 1990: 1057–68.

    Google Scholar 

  37. Forrest JD. The delivery of family planning services in the United States. Fam Plann Perspect 1988; 20: 88–98.

    Article  Google Scholar 

  38. Bennett FJ. Control of sexually transmitted diseases in the tropics and developing countries. In: Osaba AO, ed. Sexually transmitted diseases in the tropics, London: Baillière-Tyndal, 1987: 223–44.

    Google Scholar 

  39. Wasserheit JN. Reproductive tract infections. Presented at 117th Annual Meeting of the American Public Health Association, Chicago, October 17, 1989.

    Google Scholar 

  40. Stone KM, Grimes DA, Magder LS. Personal protection against sexually transmitted diseases. Am J Obstet Gynecol 1986; 155: 180–8.

    PubMed  CAS  Google Scholar 

  41. Stone KM, Grimes DA, Magder LS. Primary prevention of sexually transmitted diseases: a primer for clinicians. JAMA 1986; 255: 1763–6.

    Article  PubMed  CAS  Google Scholar 

  42. McGregor JA, French JI, Spencer NE. Prevention of sexually transmitted diseases in women. J Reprod Med 1988; 33: 109–18.

    PubMed  CAS  Google Scholar 

  43. Feldblum PJ, Fortney JA. Condoms, spermicides, and the transmission of human immunodeficiency virus: a review of the literature. Am J Public Health 1988; 78: 52–4.

    Article  PubMed  CAS  Google Scholar 

  44. Cates W Jr. STDs and contraceptive choice. Outlook 1988; 6 (2): 2–6.

    Google Scholar 

  45. North BB. Effectiveness of vaginal contraceptives in prevention of sexually transmitted diseases. In: Alexander NJ, Gabelnick HL, Spieler JM, eds. Heterosexual transmission of AIDS, New York: Wiley-Liss, 1990: 273–88.

    Google Scholar 

  46. Stone KM. Avoiding sexually transmitted diseases. Obstet Gynecol Clin N America 1990; 17: 789–99.

    CAS  Google Scholar 

  47. Hulley SB, Newman TB, Cummings SR. Getting started: the anatomy and physiology of research. In: Hulley SB, Cummings RB, eds. Designing clinical research, Baltimore: Williams and Wilkins, 1988: 1–11.

    Google Scholar 

  48. Liskin L, Wharton C, Blackburn R et al. Condoms: the challenge. Popul Rep 1990; H-8.

    Google Scholar 

  49. CDC. Condoms for prevention of sexually transmitted diseases. MMWR 1988; 37: 133–7.

    Google Scholar 

  50. Judson FN, Ehret JM, Bodin GF, Levin MJ, Rietjmeijer CAM. In vitro evaluation of condoms with and without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2 and human immunodeficiency virus. Sex Transm Dis 1989; 16: 51–6.

    Article  PubMed  CAS  Google Scholar 

  51. Conant MA, Spicer DW, Smith CD. Herpes simplex virus transmission. Sex Transm Dis 1984; 11: 94–5.

    Article  PubMed  CAS  Google Scholar 

  52. Katznelson S, Drew WL, Mintz L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis 1984; 150: 155–7.

    Article  PubMed  CAS  Google Scholar 

  53. Conant M, Hardy D, Sematinger J, Spicer D, Levy JA. Condoms prevent transmission of AIDS-associated retrovirus. JAMA 1986; 255: 1706.

    Article  PubMed  CAS  Google Scholar 

  54. Minuk GY, Bohme CE, Bowen TJ. Condoms and hepatitis B virus infection. Ann Intern Med 1986; 104: 584.

    Article  PubMed  CAS  Google Scholar 

  55. Minuk GY, Bohme CE, Bowen TJ, Cassol S. Condoms and prevention of AIDS. JAMA 1986; 256: 1443.

    Article  Google Scholar 

  56. Van de Perre P, Jacobs D, Sprecher-Goldberger S. The latex condom, an efficient barrier against sexual transmission of AIDS-related viruses. AIDS 1987; 1: 49–52.

    PubMed  Google Scholar 

  57. Lytle CD, Carney PG, Vohra S et al. Virus leakage through natural membrane condoms. Fifth International Conference on AIDS, Abstract No. M.A.P. 114, Montreal, June 4–9, 1989.

    Google Scholar 

  58. Pemberton J, McCann JS, Mahony DH, MacKenzie G, Dougan I, Hay I. Socio-medical characteristics of patients attending a VD clinic and the circumstances of infection. Br J Vener Dis 1972; 48: 391–6.

    PubMed  CAS  Google Scholar 

  59. McCormack WM, Lee Y, Zinner SH. Sexual experience and urethral colonization with genital mycoplasmas: a study in normal men. Ann Intern Med 1973; 78: 696–8.

    Article  PubMed  CAS  Google Scholar 

  60. Barlow D. The condom and gonorrhoea. Lancet 1977; 2: 811–12.

    Article  PubMed  CAS  Google Scholar 

  61. Hart G. Factors influencing venereal infection in a war environment. Br J Vener Dis 1974; 50: 68–72.

    PubMed  CAS  Google Scholar 

  62. Darrow WW. Condom use and use-effectiveness in high-risk populations. Sex Transm Dis 1989; 16: 157–60.

    Article  PubMed  CAS  Google Scholar 

  63. Oberle MW, Rosero-Bixby L, Lee FK, Sanchez-Braverman M, Nahmias AJ, Guinan ME. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hygiene 1989; 41: 224–9.

    CAS  Google Scholar 

  64. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251: 2822–4.

    Article  PubMed  CAS  Google Scholar 

  65. Syrjanen K, Vayrynen M, Catren O et al. Sexual behavior of women with human papilloma virus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984; 60: 243–8.

    PubMed  CAS  Google Scholar 

  66. Rosenberg MJ, Davidson AJ, Chen J-H, Douglas JM, Judson FN. Comparative effects of barrier contraceptives on sexually transmitted diseases in women. Submitted for publication, 1991.

    Google Scholar 

  67. Kelaghan J, Rubin GL, Ory HW, Layde PM. Barrier-method contraceptives and pelvic inflammatory disease. JAMA 1982; 248: 184–7.

    Article  PubMed  CAS  Google Scholar 

  68. Cramer DW, Goldman MB, Schiff I et al. The relationship of tubal infertility to barrier method and oral contraceptive use. JAMA 1987; 257: 2446–50.

    Article  PubMed  CAS  Google Scholar 

  69. Mann J, Quinn TC, Piot P et al. Condom use and HIV infection among prostitutes in Zaire. N Engl J Med 1987; 316: 345.

    PubMed  CAS  Google Scholar 

  70. Padian N. Male-to-female transmission of human immunodeficiency virus. JAMA 1987; 258: 3386–7.

    Article  Google Scholar 

  71. Quinn TC, Glasser D, Cannon RO et al. Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med 1988; 318: 197–203.

    Article  PubMed  CAS  Google Scholar 

  72. Smiley ML, White GC, Becherer P et al. Transmission of human immunodeficiency virus to sexual partners of hemophiliacs. Am J Hematol 1988; 28: 27–32.

    Article  PubMed  CAS  Google Scholar 

  73. Roumelioutou-Karayannis A, Nestoridou K, Mandalaki T et al. Heterosexual transmission of HIV in Greece. AIDS Res Hum Retroviruses 1988; 4: 233–6.

    Article  PubMed  CAS  Google Scholar 

  74. Fischl MA, Dickinson GM, Scott GB, Limas N, Fletcher MA, Parks W. Evaluation of heterosexual partners, children, and household contacts of adults with AIDS. JAMA 1987; 257: 6404.

    Google Scholar 

  75. Ngugi EN, Plummer FA, Simonsen JN et al. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet 1988; 2: 887–90.

    Article  PubMed  CAS  Google Scholar 

  76. Laurian Y, Peynet J, Verroust F. HIV infection in sexual partners of HIV seropositive patients with hemophilia. N Engl J Med 1989; 320: 183.

    PubMed  CAS  Google Scholar 

  77. Kamenga M, Ryder RW, Jingu M et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience in an HIV counseling center in Zaire. AIDS 1991; 5: 61–7.

    Article  PubMed  CAS  Google Scholar 

  78. Allen S, Lindan CP, Hulley S, Carael M, Black D, Coates T. Behavior change among HIV- and HIV+ urban Rwandan women. Presented at National Institute of Mental Health Workshop on HIV Prevention and Behavior Change, Washington, DC, April 4, 1991.

    Google Scholar 

  79. Trussell J, Menken J. Lifetable analysis of contraceptive failure. In: Hermalin AI, Entwisle B, eds. The role of surveys in the analysis of family planning programs, Liège: Ordina Editions, 1982: 537–71.

    Google Scholar 

  80. Trussell J. Hatcher RA, Cates W Jr, Stewart FH, Kost K. Contraceptive failure in the United States: an update. Stud Fam Plann 1990; 21: 51–4.

    Article  PubMed  CAS  Google Scholar 

  81. Nakamura RM, Coulson AH, Voeller R et al. In vitro condom testing [Abstract 6510]. In: Program and abstracts, IV international conference on AIDS, Stockholm: Stockholm International Fairs, 1988.

    Google Scholar 

  82. Free MJ, Hutchings J. Condom quality management. In: Alexander NJ, Gabelnick HL, Spieler JM, eds. Heterosexual transmission of AIDS, New York: Wiley-Liss, 1990: 370–97.

    Google Scholar 

  83. Vessey MP, Villard-Mackintosh L, McPherson K, Yeates D. Factors influencing use-effectiveness of the condom. Br J Fam Plann 1988; 14: 40–3.

    Google Scholar 

  84. Consumers Union. Can you rely on condoms? Consumer Rep 1989; (March): 135–41.

    Google Scholar 

  85. Golombok S, Sketchly J, Rust J. Condom failure among homosexual men. J AIDS 1989; 2: 404–9.

    CAS  Google Scholar 

  86. Tindall B, Swanson C, Donovan B, Cooper DA. Sexual practices and condom usage in a cohort of homosexual men in relation to human immmunodeficiency virus status. Med J Aust 1989; 151: 318–22.

    PubMed  CAS  Google Scholar 

  87. vanGriensven GJP, deVroome EMM, Tielman RAP, Coutinho RA. Failure rate of condoms during anogenital intercourse in homosexual men. Genitourin Med 1988; 64: 344–6.

    CAS  Google Scholar 

  88. Albert AE, Hatcher RA, Graves W. Condom use and breakage among women in a municipal hospital family planning clinic. Contraception 1991; 43: 167–76.

    Article  PubMed  CAS  Google Scholar 

  89. Richters J, Donovan B, Gerofi J, Watson L. Low condom breakage rate in commercial sex. Lancet 1988; 2: 1489.

    Google Scholar 

  90. Program for Appropriate Technology in Health, Program for Introduction and Adaptation of Contraceptive Technology. Monitoring condom quality. Outlook 1987; 5: 2–5.

    Google Scholar 

  91. Ahmed G, Liner EC, Williamson NE, Schellstede WP. Characteristics of condom use and associated problems: experience in Bangladesh. Contracept 1990; 42: 523–33.

    Article  CAS  Google Scholar 

  92. Wright EA, Kapu MM, Wada I. Use of condoms as contraceptive and disease preventive measures among residents of Jos, northern Nigeria. Contracept 1990; 42: 621–7.

    Article  CAS  Google Scholar 

  93. Potter LS, Clarke K. Multicountry study of acceptability of spermicidally lubricated condoms: summary report, volume 1. Research Triangle Park, NC: Family Health International, 1988. Unpublished.

    Google Scholar 

  94. Population Council. Study of the determinants and quality of condom use in two eastern Caribbean countries: Barbados and St. Lucia. Final technical report, New York, 1990.

    Google Scholar 

  95. Piedrahita C, Hinson K, Foldesy R, Steiner M, Joanis C. Latex condom breakage study, Barbados and St. Lucia condom lot. Research Triangle Park, NC: Family Health International, 1990. Unpublished.

    Google Scholar 

  96. Drew WL, Blair M, Miner RC, Conant M. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17: 110–2.

    Article  PubMed  CAS  Google Scholar 

  97. Singh B, Cutler JC, Utdjiam HMD. Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. Br J Vener Dis 1972; 48: 57–64.

    PubMed  CAS  Google Scholar 

  98. Bolch OH Jr, Warren JC. In vitro effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis. Am J Obstet Gynecol 1973; 115: 1145–8.

    PubMed  Google Scholar 

  99. Cowan ME, Cree GE. A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P. Br J Vener Dis 1973; 49: 65–6.

    CAS  Google Scholar 

  100. Singh B, Postic B, Cutler JC. Virucidal effect of certain chemical contraceptives on type 2 herpes virus. Am J Obstet Gynecol 1976; 126: 422–5.

    PubMed  CAS  Google Scholar 

  101. Asculai SS, Weis MT, Rancourt MW, Kupfenberg AB. Inactivation of herpes simplex viruses by nonionic surfactants. Antimicrob Agents Chemother 1978; 13: 686–90.

    Article  PubMed  CAS  Google Scholar 

  102. Hicks DR, Martin LS, Getchell JP et al. Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes in vitro. Lancet 1985; 2: 1422–3.

    Article  PubMed  CAS  Google Scholar 

  103. Amortegui AJ, Melder RJ, Meyer MP, Singh B. The effect of chemical intravaginal contraceptives and betadine on Ureaplasma urealyticum. Contracept 1984; 30: 135–41.

    Article  CAS  Google Scholar 

  104. Benes S, McCormack WM. Inhibition of growth of Chlamydia trachomatis by nonoxynol-9 in vitro. Antimicrob Agents Chemother 1985; 27: 724–6.

    Article  PubMed  CAS  Google Scholar 

  105. Kelly JP, Reynolds RB, Stagno S, Louv WC, Alexander WJ. In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antimicrob Agents Chemother 1985; 27: 60–2.

    Article  Google Scholar 

  106. Amortegui AJ, Myer MP. The in vitro effect of chemical intravaginal contraceptives on Chlamydia trachomatis. Contracept 1987; 36: 481–85.

    Article  CAS  Google Scholar 

  107. Kappus EW, Quinn TC. The spermicide nonoxynol-9 does not inhibit Chlamydia trachomatis in vitro. Sex Transm Dis 1986; 13: 134–7.

    Article  PubMed  CAS  Google Scholar 

  108. Quinn TW, O’Reilly KR. Contraceptive practices of women attending the sexually transmitted disease clinic in Nashville, Tennessee. Sex Transm Dis 1985; 12: 99–102.

    Article  PubMed  CAS  Google Scholar 

  109. Cole CH, Lacher TG, Bailey JC, Fairclough DL. Vaginal chemoprophylaxis in the reduction of reinfection of women with gonorrhoeae. Br J Vener Dis 1980; 56: 314–18.

    PubMed  CAS  Google Scholar 

  110. Jick H, Hannan MR, Stergachis A, Heidrich F, Perera DR. Vaginal spermicides and gonorrhea. JAMA 1982; 248: 1619–21.

    Article  PubMed  CAS  Google Scholar 

  111. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 as a prophylaxis for cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections. J Infect Dis 1988; 158: 518–23.

    Article  PubMed  CAS  Google Scholar 

  112. Cutler JC, Singh B, Carpenter U. Vaginal contraceptives as prophylaxis against gonorrhea and other sexually transmissible diseases. Adv Planned Parent 1977; 12: 45–56.

    Google Scholar 

  113. Rendon AL, Covarrubias J, McCamey KE, Marion-Landais G, Luna del Villar J. A controlled, comparative study of phenylmercuric acetate, nonoxynol-9 and placebo vaginal suppositories as prophylactic agents against gonorrhea. Curr Ther Res 1980; 27: 780–3.

    Google Scholar 

  114. Berger GS, Keith L, Moss W. Prevalence of gonorrhea among women using various methods of contraception. Br J Vener Dis 1975; 51: 307–9.

    PubMed  CAS  Google Scholar 

  115. Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydia trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol 1988; 28: 298–308.

    Google Scholar 

  116. Rosenberg MJ, Rojanapithayakom W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis. A comparative clinical trial. JAMA 1987; 257: 2308–12.

    Article  PubMed  CAS  Google Scholar 

  117. Kjaer SK, Engholm G, Teisen C et al. Risk factors for cervical human papilloma virus and herpes simplex virus infections in Greenland and Denmark: a population-based study. Am J Epidemiol 1990; 131: 669–82.

    PubMed  CAS  Google Scholar 

  118. Hooton RM, Hillier S, Johnson C, Roberts PL, Stamm WE. Escherichia coli bacteriuria and contraceptive method. JAMA 1991; 265: 64–9.

    Article  PubMed  CAS  Google Scholar 

  119. Eschenbach DA, Hillier S, Critchlow C et al. Diagnosis and clinical manifestations of bacterial vaginosis. Am J Obstet Gynecol 1988; 158: 819–28.

    PubMed  CAS  Google Scholar 

  120. Kreiss J, Ruminjo I, Ngugi E, Roberts P, Ndinya-Achola J, Plummer F. Efficacy of nonoxynol-9 in preventing HIV transmission. F.fth International Conference on AIDS, Abstract No. MAO 361, Montreal, June 5, 1989.

    Google Scholar 

  121. Reckart ML, Barnett JA, Manzon LM, Wittenberg L, McNabb A. Nonoxynol-9: its adverse effects. Sixth International Conference on AIDS, Abstract No. SC 36, San Francisco, June 23, 1990.

    Google Scholar 

  122. Trap R, Trap B, Peterson CS. Evaluation of the amount of nonoxynol-9 available in condoms for the inhibition of HIV using a method based on HPLC. Int J STD AIDS 1990; 1: 346–8.

    PubMed  CAS  Google Scholar 

  123. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. JAMA 1985; 253: 2246–50.

    Article  PubMed  CAS  Google Scholar 

  124. McCormack WM, Rosner B, McComb DE et al. Infection with Chlamydia trachomatis in female college students. Am J Epidemiol 1985; 121: 107–15.

    PubMed  CAS  Google Scholar 

  125. Handsfield HH, Jasman LL, Robert PL et al. Criteria for selective screening for Chlamydial trachomatis infection in women attending family planning clinics. JAMA 1986; 255: 1730–34.

    Article  PubMed  CAS  Google Scholar 

  126. Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 1990; 17: 23–29.

    PubMed  CAS  Google Scholar 

  127. Harrison HR, Costin M, Meder JB et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Am J Obstet Gynecol 1985; 153: 244–51.

    PubMed  CAS  Google Scholar 

  128. Weström L. Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries. Am J Obstet Gynecol 1980; 138: 880–92.

    PubMed  Google Scholar 

  129. Eschenbach DA, Hamish JP, Holmes KK. Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol 1977; 128: 838–50.

    PubMed  CAS  Google Scholar 

  130. Royal College of General Practitioners Oral Contraception Study. Oral contraceptives and health, New York: Pitman, 1974.

    Google Scholar 

  131. Panser LA, Phipps WR. Type of oral contraceptive in relation to acute, initial episodes of pelvic inflammatory disease. Contraception 1991; 93: 91–9.

    Article  Google Scholar 

  132. Rubin GL, Ory HW, Layde PM. Oral contraceptives and pelvic inflammatory disease. Am J Obstet Gynecol 1982; 144: 630–5.

    PubMed  CAS  Google Scholar 

  133. Wolner-Hanssen P, Svensson L, Mardh P-A, Weström L. Laparoscopic findings and contraceptive use in women with signs and symptoms suggestive of acute salpingitis. Obstet Gynecol 1985; 66: 233–8.

    PubMed  CAS  Google Scholar 

  134. Wolner-Hanssen P, Eschenbach DA, Paavonen J et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990; 263: 54–9.

    Article  PubMed  CAS  Google Scholar 

  135. Wolner-Hanssen P. Oral contraceptive use modifies the manifestations of pelvic inflammatory disease. Br J Obstet Gynaecol 1986; 93: 619–24.

    Article  PubMed  CAS  Google Scholar 

  136. Svensson L, Weström L, Mârdh P-A. Contraceptives and acute salpingitis. JAMA 1984; 251: 2553–5.

    Article  PubMed  CAS  Google Scholar 

  137. Grossman C. Possible underlying mechanisms of sexual dimorphism in the immune response, fact and hypothesis. J Steroid Biochem 1989; 34: 241–51.

    Article  PubMed  CAS  Google Scholar 

  138. Hunter DJ, Mati JK. Contraception, family planning, and HIV. Presented at the International Workshop on AIDS and Reproductive Health, Bellagio, Italy, October 1990. To be published by Plenum Press in AIDS and Women’s Health.

    Google Scholar 

  139. Plummer FA, Simonsen JN, Cameron DW et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233–39.

    Article  PubMed  CAS  Google Scholar 

  140. Hira SK, Kamanga J, Macuacua R, Feldblum PJ. Oral contraceptive use and HIV infection. Int J STD AIDS 1990; 1: 447–8.

    PubMed  CAS  Google Scholar 

  141. Simonsen JN, Plummer FA, Ngugi EN et al. HIV infection among lower socioeconomic strata prostitutes in Nairobi. AIDS 1990; 4: 139–44.

    Article  PubMed  CAS  Google Scholar 

  142. Darrow WW, CDC Collaborative Group. Human immunodeficiency virus type 1 and other sexually transmitted infections in American prostitutes. Am J Epidemiol, 1991 (in press).

    Google Scholar 

  143. Carael M, Van de Perre PH, Lepage PH et al. Human immunodeficiency virus transmission among heterosexual couples in Central Africa. AIDS 1988; 2: 201–5.

    Article  PubMed  CAS  Google Scholar 

  144. Latif AS, Katzenstein DA, Bassett MT, Houston S, Emmanuel JC, Marowa E. Genital ulcers and transmission of HIV among couples in Zimbabwe. AIDS 1989; 3: 519–23.

    Article  PubMed  CAS  Google Scholar 

  145. Siraprasiri T, Thanprasertsuk S, Rodklay A et al. Study of risk factors for HIV infection among prostitutes in Chiengmai, Thailand. Presented at Field Epidemiology Training Program Second International Conference, Puebla, Mexico, January 1990.

    Google Scholar 

  146. Mati J, Maggwa A, Chewe D et al. Contraceptive use and HIV infection among women attending family planning clinics in Nairobi. Sixth International Conference on AIDS, Abstract No. Th.C.99, San Francisco, June 24, 1990.

    Google Scholar 

  147. European Study Group. Risk factors for male to female transmission of HIV. Br Med J 1989; 298: 411–15.

    Article  Google Scholar 

  148. Musicco M, The Italian Partners’ Study. Oral contraception, IUD, condom use and man to woman sexual transmission of HIV infection. Sixth International Conference on AIDS, Abstract No. Th.C. 584, San Francisco, June 24, 1990.

    Google Scholar 

  149. Edelman DA. The use of intrauterine contraceptive devices, pelvic inflammatory disease, and Chlamydia trachomatis infection. Am J Obstet Gynecol 1988; 158: 956–9.

    PubMed  CAS  Google Scholar 

  150. Daling JR, Department of Epidemiology, University of Washington, School of Public Health. Personal communication, March 28, 1991.

    Google Scholar 

  151. Kronmal RA, Whitney CW, Mumford SD. The intrauterine device and pelvic inflammatory disease: the Women’s Health Study reanalyzed. J Clin Epidemiol 1991; 44: 109–22.

    Article  PubMed  CAS  Google Scholar 

  152. Burkman RT, Lee NC, Ory HW, Rubin GL. Response to “The intrauterine device and pelvic inflammatory disease: the Women’s Health Study reanalyzed. ” J Clin Epidemiol 1991; 44: 123–5.

    Article  PubMed  CAS  Google Scholar 

  153. Senanayake P, Kramer DG. Contraception and the etiology of pelvic inflammatory disease: new perspectives. Am J Obstet Gynecol 1980; 138: 852–60.

    PubMed  CAS  Google Scholar 

  154. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease: a comprehensive analysis and new algorithm. JAMA, 1991 (in press).

    Google Scholar 

  155. Paavonen J, Vesterinen E. Intrauterine contraceptive device use in patients with acute salpingitis. Contraception 1980; 22: 107–14.

    Article  PubMed  CAS  Google Scholar 

  156. Burkman RT, Women’s Health Study. Association between intrauterine device and pelvic inflammatory disease. Obstet Gynecol 1981; 57: 269–76.

    PubMed  CAS  Google Scholar 

  157. Kaufman DW, Watson J, Rosenberg L et al. The effect of different types of intrauterine devices on the risk of pelvic inflammatory disease. JAMA 1983; 250: 759–62.

    Article  PubMed  CAS  Google Scholar 

  158. Lee NC, Rubin GL, Ory HW, Burkman RT. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983; 62: 1–6.

    PubMed  CAS  Google Scholar 

  159. Witoonpanich P, Koetsawang A, Koetsawang S et al. PID associated with fertility regulating agents. Contraception 1984; 30: 1–21.

    Article  Google Scholar 

  160. Vessey MP, Yeates D, Flavel R, McPherson K. Pelvic inflammatory disease and the intrauterine device: findings in a large cohort study. Br Med J 1981; 282: 855–7.

    Article  CAS  Google Scholar 

  161. Buchan H, Villard-Mackintosh L, Vessey M, Yeates D, McPherson K. Epidemiology of pelvic inflammatory disease in parous women with special reference to intrauterine device use. Br J Obstet Gynaecol 1990; 97: 780–88.

    Article  PubMed  CAS  Google Scholar 

  162. Grimes DA. Intrauterine devices and pelvic inflammatory disease: recent developments. Contracept 1987; 36: 97–109.

    Article  CAS  Google Scholar 

  163. Sinei SKA, Schulz KF, Lamptey PR et al. Preventing IUD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 1990; 97: 412–9.

    Article  PubMed  CAS  Google Scholar 

  164. Ladipo OA, Farr G, Otolorin E et al. Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion. Adv Contracept 1991; 7: 43–54.

    Article  PubMed  CAS  Google Scholar 

  165. Cramer DW, Schiff I, Schoenbaum SC et al. Tubal infertility and the intrauterine device. N Engl J Med 1985; 312: 941–7.

    Article  PubMed  CAS  Google Scholar 

  166. Daling JR, Weiss NS, Metch DJ et al. Primary tubal infertility in relation to the use of an intrauterine device. N Engl J Med 1985; 312: 937–41.

    Article  PubMed  CAS  Google Scholar 

  167. Falk HC. Interpretation of the pathogenesis of pelvic infection as determined by cornual resection. Am J Obstet Gynecol 1946; 52: 66–72.

    PubMed  CAS  Google Scholar 

  168. Haji SN. Does sterilization prevent pelvic infection? J Reprod Med 1978; 20: 289–90.

    Google Scholar 

  169. Vessey M, Huggins G, Lawless M, Yeates D, McPherson K. Tubal sterilization: findings in a large prospective study. Br J Obstet Gynaecol 1983; 90: 203–9.

    Article  PubMed  CAS  Google Scholar 

  170. Huggins GR, Sondheimer SJ. Complications of female sterilization: immediate and delayed. Fertil Steril 1984; 41: 337–55.

    PubMed  CAS  Google Scholar 

  171. Vermesh M, Confino E, Boler LR, Friberg J, Gleicher N. Acute salpingitis in sterilized women. Obstet Gynecol 1987; 69: 265–7.

    PubMed  CAS  Google Scholar 

  172. Edelman DA, Berger GS. Contraceptive practice and tuboovarian abscess. Am J Obstet Gynecol 1980; 138: 541–5.

    PubMed  CAS  Google Scholar 

  173. Burkman RT, Tonascia JA, Atienza M, King TM. Untreated endocervical gonorrhea and endometritis following elective abortion. Am J Obstet Gynecol 1976; 126: 648–51.

    PubMed  CAS  Google Scholar 

  174. Osser S, Persson K. Postabortal pelvic infection associated with Chlamydia trachomatis and the influence of humoral immunity. Am J Obstet Gynecol 1984; 150: 699–703.

    PubMed  CAS  Google Scholar 

  175. Westergaard L, Philipsen T, Scheibel J. Significance of cervical Chlamydia trachomatis infection in postabortal pelvic inflammatory disease. Obstet Gynecol 1982; 60: 322–5.

    PubMed  CAS  Google Scholar 

  176. Grimes DA, Schulz KF, Cates W Jr. Prophylactic antibiotics for curettage abortions. Am J Obstet Gynecol 1984; 150: 689–94.

    PubMed  CAS  Google Scholar 

  177. Park TK, Flock M, Schulz KF, Grimes DA. Preventing febrile complications of suction curettage abortion. Am J Obstet Gynecol 1985; 152: 252–5.

    PubMed  CAS  Google Scholar 

  178. Darj E, Stralm E-B, Nilsson S. The prophylactic effect of doxycycline on postoperative infection rate after first-trimester abortion. Obstet Gynecol 1987; 70: 755–8.

    PubMed  CAS  Google Scholar 

  179. Qvigstad E, Skaug K, Jerve F, Vik ISS, Ulstrup JC. Therapeutic abortion and Chlamydia trachomatis infection. Br J Vener Dis 1982; 58: 182–3.

    PubMed  CAS  Google Scholar 

  180. Osser S, Persson K. Postabortal pelvic infection associated with Chlamydia trachomatis and the influence of humoral immunity. Am J Obstet Gynecol 1984; 150: 699–703.

    PubMed  CAS  Google Scholar 

  181. Barbacci MB, Spence MR, Kappus EW, Burkman RC, Rao L, Quinn TC. Postabortal endometritis and isolation of Chlamydia trachomatis. Obstet Gynecol 1986; 68: 686–90.

    PubMed  CAS  Google Scholar 

  182. Heisterberg L, Möller BR, Manthorpe T, Sorensen S, Petersen K, Nielsen NC. Prophylaxis with lymecycline in induced first-trimester abortion: a clinical controlled trial assessing the role of Chlamydia trachomatis and Mycoplasma hominis. Sex Transm Dis 1985; 12: 782–5.

    Google Scholar 

  183. Schioötz H, Csango PA. A prospective study of Chlamydia trachomatis in first trimester abortion. Ann Clin Res 1985; 17: 60–3.

    Google Scholar 

  184. Giertz G, Kallings I, Nordenvall M, Fuchs T. A prospective study of Chlamydia trachomatis infection following legal abortion. Acta Obstet Gynecol Scand 1987; 66: 107–9.

    Article  PubMed  CAS  Google Scholar 

  185. Liskin L. Complications of abortion in developing countries. Popul Rep 1980; F-7:1–32.

    Google Scholar 

  186. Coeytaux F. Induced abortion in Sub-Saharan Africa: what we do and do not know. Stud Fam Plann 1988; 19: 186–90.

    Article  PubMed  CAS  Google Scholar 

  187. Sherris J. The impact of unsafe abortion in the developing world. Outlook 1989; 7 (3): 2–7.

    Google Scholar 

  188. Henshaw SK. Induced abortion: a world review, 1990. Fam Plann Perspect 1990; 22: 76–89.

    Article  PubMed  CAS  Google Scholar 

  189. Moreno L, Goldman N. Contraceptive failure rates in developing countries: evidence from the Demographic and Health Surveys. Int Fam Plann Perspect 1991; 17: 44–9.

    Article  Google Scholar 

  190. Kestelman P, Trussell J. Efficacy of combined barrier contraceptives. Submitted to Fam Plann Perspect, 1991.

    Google Scholar 

  191. United Nations Family Planning Association. Levels and trends of contraceptive use as assessed in 1988, New York: United Nations, 1989.

    Google Scholar 

  192. Judson FN. Fear of AIDS and gonorrhea rates in homosexual men. Lancet 1983; 2: 159.

    Article  PubMed  CAS  Google Scholar 

  193. Handsfield HH. Decreasing incidence of gonorrhea in homosexually active men-minimal effect on risk of AIDS. West J Med 1985; 143: 469–72.

    PubMed  CAS  Google Scholar 

  194. Alter MJ, Hadler SC, Margolis HS et al. The changing epidemiology of hepatitis B in the United States. JAMA 1990; 263: 1218–22.

    Article  PubMed  CAS  Google Scholar 

  195. Sorvillo FJ, Lieb L, Mascola L, Waterman SH. Declining rates of amebiasis in Los Angeles County. Am J Public Health 1989; 79: 1563–4.

    Article  PubMed  CAS  Google Scholar 

  196. Bertrand JR, Makani B, Hassig SE et al. AIDS-related knowledge, sexual behavior and condom use among men and women in Kinshasa, Zaire. Am J Public Health 1991; 81: 53–8.

    Article  PubMed  CAS  Google Scholar 

  197. Goldberg HI, Lee NC, Oberle MW, Peterson HB. Knowledge about condoms and their use in less developed countries during a period of rising AIDS prevalence. Bull WHO 1989; 67: 85–91.

    PubMed  CAS  Google Scholar 

  198. Cates W Jr, Farley TMM, Rowe PJ, WHO Task Force on Infertility. Worldwide patterns of infertility: Is Africa different? Lancet 1985; 2: 596–8.

    Article  Google Scholar 

  199. WHO Task Force on Infertility (Cates W Jr, Farley TMM, Rowe PJ). Infections, pregnancies and infertility: perspectives on prevention. Fertil Steril 1987; 47: 964–8.

    Google Scholar 

  200. Bowen GS, Aral SO, Magder LS, Reed DS, Dratman C, Wasser S. Risk behaviors for HIV infection in clients of Pennsylvania family planning clinics. Fam Plann Perspect 1990; 22: 62–4.

    Article  PubMed  CAS  Google Scholar 

  201. Upchurch DM, Farmer MY, Glasser D, Hook EW III. Contraceptive needs and practices among women attending an inner city STD clinic. Am J Public Health 1987; 77: 1427–30.

    Article  PubMed  CAS  Google Scholar 

  202. Bureau of Community Health Services. Guidelines for health promotion and disease prevention services in reproductive health care settings, Washington, DC, and Rockville, Maryland, 1981.

    Google Scholar 

  203. Brown ST, Wiesner PJ. Problems and approaches to the control and surveillance of sexually transmitted agents associated with pelvic inflammatory disease in the United States. Am J Obstet Gynecol 1980; 138: 1096–1100.

    PubMed  CAS  Google Scholar 

  204. Aral SO, Mosher WD, Horn MC, Cates W Jr. Screening for sexually transmitted diseases by family planning providers: is it adequate and appropriate? Fam Plann Perspect 1986; 18: 255–8.

    Article  PubMed  CAS  Google Scholar 

  205. Schachter J, Stoner E, Moncada J. Screening for chlamydial infections in women attending family planning clinics-evaluation of presumptive indicators for therapy. West J Med 1983; 138: 375–9.

    PubMed  CAS  Google Scholar 

  206. Addiss DG, Vaughn ML, Holzhueter MA, Bakken LL, Davis JP. Selective screening for Chlamydia trachomatis infection in nonurban family planning clinics in Wisconsin. Fam Plann Perspect 1987; 19: 252–6.

    Article  PubMed  CAS  Google Scholar 

  207. Bagshaw SN, Edwards D. Risk factors for Chlamydia trachomatis infection of the cervix: a prospective study of 2,000 patients at a family planning clinic. N Z Med J 1987; 100: 401–3.

    PubMed  CAS  Google Scholar 

  208. Binns B, Williams T, McDowell J, Brunham RC. Screening for Chlamydia trachomatis infection in a pregnancy counseling clinic. Am J Obstet Gynecol 1988; 159: 1144–9.

    PubMed  CAS  Google Scholar 

  209. Begley CE, McGill L, Smith PB. The incremental cost of screening, diagnosis, and treatment of gonorrhea and chlamydia in a family planning clinic. Sex Transm Dis 1989; 16: 63–7.

    Article  PubMed  CAS  Google Scholar 

  210. Stein ZA. The need for methods women can use. Am J Public Health 1990; 80: 460–2.

    Article  PubMed  CAS  Google Scholar 

  211. Aral SO, Cates W Jr, Beral V. Are sexually transmitted diseases (STD) inherently sexist? Gender as a risk factor in STD epidemiology. In: Blumenthal S, Eichler A, Weissman G, eds. Women and AIDS, Washington, DC: American Psychological Press (in press).

    Google Scholar 

  212. World Health Organization. AIDS prevention: guidelines for MCH/FP programme managers. I. AIDS and family planning. Geneva, 1990: 29–38.

    Google Scholar 

  213. Wasserheit JN. Epidemiological synergy. Interrelationships between HIV infection and other STDs. Presented at the International Workshop on AIDS and Reproductive Health, Bellagio, Italy, October 29, 1990. To be published by Plenum Press in AIDS and Women’s Health.

    Google Scholar 

  214. Bayer R. AIDS and the future of reproductive freedom. Milbank Quart 1990; 8 (Suppi 2): 179–204.

    Article  Google Scholar 

  215. Levine C, Dubler NN. HIV and childbearing: 1) Uncertain risks and bitter realities: the reproductive choices of HIV-infected women. Milbank Quart 1990; 68: 321–51.

    Article  CAS  Google Scholar 

  216. Arras JD. HIV and childbearing: 2) AIDS and reproductive decisions: having children in fear and trembling. Milbank Quart 1990; 68: 353–82.

    Article  CAS  Google Scholar 

  217. Holmes KK, Karon JM, Kreiss J. The increasing frequency of heterosexually acquired Aids in the United States, 1983–1988. Am J Public Health 1990; 80: 858–62.

    Article  PubMed  CAS  Google Scholar 

  218. Donovan P. AIDS and family planning clinics: confronting the crisis. Fam Plann Perspect 1987; 19: 111–38.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Training, Epidemiology Program Office, USA

    Willard Cates Jr., M.D., M.P.H.

  2. Clinical Research Investigator Division of STD/HIV Prevention, USA

    Katherine M. Stone M.D. (Director)

  3. Centers for Disease Control, 1600 Clifton Road, Mailstop EO2, Atlanta, GA, 30333, USA

    Willard Cates Jr., M.D., M.P.H. & Katherine M. Stone M.D. (Director)

Authors
  1. Willard Cates Jr., M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katherine M. Stone M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. International Women’s Health Coalition, New York, New York, USA

    Adrienne Germain

  2. University of Washington, Seattle, Washington, USA

    King K. Holmes

  3. Institut de Medicina Tropicale, Antwerp, Belgium

    Peter Piot

  4. National Institutes of Health, Bethesda, Maryland, USA

    Judith N. Wasserheit

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Cates, W., Stone, K.M. (1992). Family Planning: The Responsibility to Prevent Both Pregnancy and Reproductive Tract Infections. In: Germain, A., Holmes, K.K., Piot, P., Wasserheit, J.N. (eds) Reproductive Tract Infections. Reproductive Biology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0691-5_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0691-5_5

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0693-9

  • Online ISBN: 978-1-4899-0691-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation